Getting treatment for
early-stage non-small cell lung cancer (NSCLC) before and after surgery
Given before and after surgery to adults with non-small cell lung cancer
Actor portrayals.
OPDIVO + chemotherapy and OPDIVO alone as well as
OPDIVO Qvantig + chemotherapy and OPDIVO Qvantig alone
are not approved for people younger than 18 years of age.
Your treatment plan has 2 parts
Before surgery:
After surgery, this treatment uses 1 medication
Before surgery, you will get up to 4 treatments as long as your treatment is working and side effects are manageable. Then, you will have surgery with timing determined by your healthcare team. After surgery, your treatment will continue as long as it is working and side effects are manageable, or up to 13 cycles (~1 year).
Talk to your doctor about your plan and ask any questions you may have before starting treatment. Only your doctor can make specific recommendations about your treatment.
Learn more about the differences between OPDIVO infusions and OPDIVO Qvantig injections below so you can have an informed discussion with your healthcare provider.
Sign up for support
Learn more about the complimentary OPDIVO with You support program
Helpful patient resources
Explore resources to help you along your treatment journey
Clinical trial results and side effects
Explore findings from clinical trials and view possible side effects of treatment